
Northern Ireland CDMO, privately held. Founded 1969, headquartered in Craigavon. Over £400M ($500M) expansion program completed 2024, including new 28,000 sq ft GMP peptide API facility doubling capacity. MHRA audited. Offers peptide synthesis from research to commercial scale.
Claim this listing to update your information, respond to buyer inquiries, and get a verified badge.
Free to claim. Verified upgrades available.